- A tech healthtech company, CarePoint has secured N4.1 billion in funding to grow its company across Africa
- The funding was led TRB advisors and other funders who said they believe in the company's prospects
- CarePoint said the new fund would be used to accelerate its process of setting up telemedicine centres across the continent
A tech-driven healthcare startup, CarePoint has secured a N4.150 billion in funding to grow its services across Africa.
The startup operates in Nigeria, Kenya, Ghana and Egypt and is planning to expand to North and East Africa in order to continue its growth which is driven by mergers and acquisitions.
Targeting more tech-driven services
According to Nairametrics, the new funding was led TRB Advisors which bought the total funding raised by CarePoint to $30 million. This comes as an $18 million Series A round announced in November last year.
PAY ATTENTION: Share your outstanding story with our editors! Please reach us through email@example.com!
Other investors include Delle, Breyer Capital, Beyond Capital Ventures (BVC), M3, Inc, Asia Pacific Land/Natural World Limited, and Alan Waxman, a Sixt Street Partners’ CEO.
Virtual care available, CarePoint says
The CEO of the company, Dr. Sangu Delle stated that the firm is in the process of setting up telemedicine centres in their facilities and building micro-tech-enablers-centres which is targeted at people, saying this will grow the company which was formerly known as Africa Health Holdings.
The company said patients can also have access to virtual care through the company’s MyCareMobile app, which links them to various services via teleconferencing, including consultations with doctors, test results and 24-hour emergency response.
Pharmaceutical company, Africure secures N6.2 billion funding for Pan-African expansion
Legit.ng has reported that pharmaceutical products makers and distributors, Africure has secured N6.2 billion in seed funding to grow its African market.
The firm secured the funds from BluePeak Private Capital’s $200 million targeted impact fund.
The new funding is meant to provide an important growth to the company and support its plan to strengthen its operational capital and boost demands for its pharmaceutical goods across 10 markets in Africa, reports by Nairametrics indicate.